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Abstract 22 
Evolutionary hypotheses predict that male fetuses are more vulnerable to poor maternal 23 
conditions (Sex-biased Maternal Investment), but female fetuses are at greater risk of 24 
glucocorticoid-mediated disorders where there is a mismatch between fetal and postnatal 25 
environments (Predictive Adaptive Response). Self-reported prenatal and postnatal depression 26 
and maternal report of child anxious-depressed symptoms at 2.5, 3.5 and 5.0 years were 27 
obtained from an ‘extensive’ sample of first-time mothers (N=794). Salivary NR3C1 1-F 28 
promoter methylation was assayed at 14 months in an ‘intensive’ subsample (n=176), stratified 29 
by psychosocial risk. Generalised structural equation models were fitted and estimated by 30 
maximum likelihood to allow inclusion of participants from both intensive and extensive 31 
samples. Postnatal depression was associated with NR3C1 methylation and anxious-depressed 32 
symptoms in daughters of mothers with low prenatal depression (prenatal-postnatal depression 33 
interaction for methylation, p<.001; for child symptoms, p=.011). In girls, NR3C1 methylation 34 
mediated the association between maternal depression and child anxious-depressed symptoms. 35 
Effects were greater in girls than boys: the test of sex differences in the effect of the prenatal-36 
postnatal depression interaction on both outcomes gave 2(2)=5.95 (p=.051). This is the first 37 
study to show in humans that epigenetic and early behavioural outcomes may arise through 38 
different mechanisms in males and females.  39 
 40 
Key Words: maternal depression: NR3C1 methylation; child anxiety-depression: sex 41 
differences: parental reproductive investment: epidemiological sampling: mediation: 42 
longitudinal design  43 
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Introduction 44 
The ‘fetal origins’ hypothesis was first proposed to account for associations between low birth 45 
weight and obesity, cardiovascular disease, and Type II diabetes in middle and old age [1]. 46 
According to this hypothesis, low birth weight reflects evolved adaptive mechanisms that 47 
confer advantages later in life where food is scarce, but create risk in the presence of high 48 
calorie diets, common in industrialised societies. Far from being a mechanism specific to 49 
nutrition in humans, adaptations prior to birth that anticipate later environments are found 50 
across species, possibly reflecting a conserved ‘Predictive Adaptive Response’ (PAR) 51 
mechanism [2, 3]. According to the PAR hypothesis, matched prenatal and postnatal conditions 52 
will be associated with good outcomes, while mismatching creates risks for poor outcomes. In 53 
relation to effects on psychiatric disorders, many studies have reported that anxiety, depression 54 
and behavioural symptoms in children are predicted by prenatal stressors, maternal depression 55 
and anxiety, and by low birth weight [4 - 9]. We have previously reported that the association 56 
between prenatal anxiety and child emotional and behavioural outcomes is seen only in the 57 
presence of low maternal stroking, consistent with animal studies of the protective effects of 58 
postnatal tactile stimulation [8]. We went on to show that mismatched prenatal – postnatal 59 
maternal anxiety is associated with elevated child irritability at age 7 years, only in the presence 60 
of low maternal stroking [10], consistent with a mismatch effect creating vulnerability that is 61 
modified by early tactile stimulation.  62 
Fetal adaptations may additionally vary by sex of the fetus. According to the Trivers-63 
Willard (T-W) hypothesis, if maternal health during pregnancy predicts later reproductive 64 
fitness in the offspring, then a male predominance of births will be favoured when maternal 65 
conditions are good, because healthy males compete successfully for females. By contrast, 66 
when maternal conditions are poor, the sex ratio will be reversed, both to avoid bearing males 67 
who compete less successfully for females, but also because, compared to females, health 68 
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outcomes for mothers following male births are poorer [11]. Although this hypothesis has been 69 
subject to challenges and modifications [12], the central idea that reproductive strategies 70 
associated with poor maternal conditions involve sacrifice of males and protection of females 71 
has received substantial support. It is also consistent with well documented observations that 72 
male fetuses are more vulnerable to threats such as preterm birth and are more likely to suffer 73 
neurodevelopmental consequences of fetal insults [13]. This hypothesis would appear to 74 
predict better outcomes for females following poor maternal conditions. However, if this 75 
protective effect in females arises from advantages conferred by fetal anticipation of matched 76 
environments (PAR hypothesis), mismatches between maternal conditions during pregnancy 77 
and the postnatal environment will create vulnerability. Combining the T-W and PAR 78 
hypotheses leads to the prediction that the effects of prenatal risks will operate differently in 79 
males and females. In females, vulnerability will be generated by particular combinations of 80 
prenatal and postnatal risks, while in males, poor outcomes will arise incrementally from 81 
degree of prenatal risk. In the only human study we are aware of to have examined the 82 
combined effects predicted by the T-W and PAR hypotheses, matched environments indexed 83 
by prenatal and postnatal depression (low-low and high-high) were associated with better 84 
cognitive and motor outcomes over the first year of life than mismatched prenatal and postnatal 85 
depression, and this effect was seen in females only [14]. However, many studies have reported 86 
sex differences in developmental outcomes in relation to prenatal risks, without examining for 87 
the interplay with postnatal environments. Sex differences in fetal responses to stress [15], and 88 
in later emotional and behavioural problems following maternal anxiety or depression during 89 
pregnancy and low birth weight [4, 7, 8, 16, 17], have been identified. 90 
In animal models, prenatal and postnatal stress cause long-term elevations in 91 
hypothalamic pituitary axis (HPA) reactivity and anxiety-like behaviours. This is mediated via 92 
reduced glucocorticoid receptor (GR) gene NR3C1 expression, particularly in the hippocampus 93 
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which impairs HPA axis feedback mechanisms [18]. The epigenetic process of DNA 94 
methylation involves the addition of methyl groups to CpG dinucleotides in gene regulatory 95 
regions that are associated with repressed gene expression. Animal findings of the epigenetic 96 
effects of early life stress have been translated to humans in a study reporting elevated NR3C1 97 
1-F promoter methylation and reduced NR3C1 expression in post-mortem hippocampal tissue 98 
of people who have committed suicide and who were abused during childhood, when compared 99 
to non-abused [19]. Other studies using peripheral DNA from blood or saliva of infants and 100 
adolescents have shown increased levels of NR3C1 methylation associated with prenatal and 101 
childhood adversities [20, 21, 22]. Several clinical studies examining leukocytes have reported 102 
elevated methylation of the homologous human NR3C1 1-F promoter (homologous to the rat 103 
1-7 promoter) at a specific CpG (CpG unit 22,23, Figure 1) associated with prenatal maternal 104 
depression [19, 23-25] and childhood stress [26]. Studies in humans also find associations 105 
between prenatal anxiety and postnatal depression in mothers, and adolescent depressive 106 
symptoms mediated via HPA axis dysregulation [27, 28], consistent with the role of HPA axis 107 
dysregulation in adolescent depression [29].  Higher NR3C1 methylation levels, hypothesised 108 
to contribute to reduced NR3C1 expression (19), have been associated with increased salivary 109 
cortisol stress responses in infants at 3 months [20] and a flattened cortisol recovery slope 110 
following stress in adolescents [30], suggesting methylation of NR3C1 may impair negative 111 
feedback of the HPA axis. 112 
In the first study to examine the interplay between prenatal and postnatal depression in 113 
relation to NR3C1 gene methylation, we showed that the association between postnatal 114 
maternal depression and NR3C1 1-F promoter methylation in children was stronger where 115 
mothers had reported lower depression during pregnancy, in line with the PAR hypothesis [31]. 116 
However, we did not examine for sex differences. Sex differences in glucocorticoid 117 
mechanisms associated with prenatal stress have been shown in animal models. In rats, many 118 
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effects of prenatal stress on later development are seen only in females, and these are abolished 119 
by adrenalectomy [32]. The effects predicted by a combination of the T-W and PAR 120 
hypotheses, have been demonstrated in starlings where mismatched prehatch-posthatch 121 
conditions had a greater effect on corticosterone levels in female than male chicks, but prenatal 122 
risk increased mortality in male chicks [33, 34]. In humans, a sex difference in associations 123 
between prenatal depression and NR3C1 1-F promoter methylation has been reported [35], 124 
although the interplay with postnatal depression however was not analysed.  125 
In this study we examined predictions based on the T-W sex-biased parental investment 126 
and PAR hypotheses. In females, where individual and species vulnerability are reduced by 127 
matching environments but increased by mismatching, the presence of good prenatal 128 
conditions followed by adverse rearing experiences, and vice versa, will create vulnerability to 129 
child anxiety and depression. Based on the animal models, we predicted this effect in females 130 
will involve altered HPA axis reactivity arising from epigenetic modifications of the GR gene. 131 
In males, where individuals are sacrificed for species advantage, the presence of prenatal stress 132 
will create vulnerability, unmodified by later environment quality. The animal models suggest 133 
that glucocorticoid mechanisms are implicated in excess male deaths under unfavourable 134 
maternal conditions, but they may not contribute to effects of prenatal stress on functioning 135 
after birth.  136 
These predictions were tested in a longitudinal study using measures of prenatal and 137 
postnatal depression, of NR3C1 1-F promoter region methylation at 14 months of age, and 138 
anxious depressed symptoms in children across the preschool period. We predicted that in girls 139 
but not boys, low prenatal depression followed by high postnatal maternal depression, and high 140 
prenatal depression followed by low postnatal depression will be associated with elevated 141 
anxious depressed symptoms and elevated NR3C1 methylation which will mediate the 142 
association between mismatched maternal depression and child anxious depressed symptoms. 143 
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In boys, prenatal and postnatal depression will be independent risks for elevated anxious-144 
depressed symptoms, without the interaction between them predicted for females.    145 
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Materials and Methods 146 
Design 147 
The participants were members of the Wirral Child Health and Development Study, a 148 
prospective epidemiological longitudinal cohort of first-time mothers recruited in pregnancy 149 
to study prenatal and infancy origins of emotional and behavioural disorders. The full cohort 150 
of 1233 mothers with live singleton births have participated in several waves of assessment 151 
with a stratified random sub-sample of 316 identified for additional, more intensive assessment 152 
(intensive sample).  Strata were defined on the basis of low, medium and high psychosocial 153 
risk (scores of <=2, 3 or >3 on an inter-partner psychological abuse scale provided on entry to 154 
the study at 20 weeks of pregnancy), with higher selection probabilities for those at higher risk.  155 
Appropriately analysed, the design allows estimates of means and coefficients for the whole 156 
general population cohort to be derived even for measures available only in the intensive 157 
sample [36].  158 
Approval for the procedures was obtained from the Cheshire North and West Research 159 
Ethics Committee (UK) (reference no. 05/Q1506/107).  The extensive sample was identified 160 
from consecutive first-time mothers who booked for antenatal care at 12 weeks gestation 161 
between 12/02/2007 and 29/10/2008. The booking clinic was administered by the Wirral 162 
University Teaching Hospital which was the sole provider of universal prenatal care on the 163 
Wirral Peninsula. Socioeconomic conditions on the Wirral range between the deprived inner 164 
city and affluent suburbs, but with few from ethnic minorities. The study was introduced to the 165 
women by clinic midwives who asked for their agreement to be approached by study research 166 
midwives when they attended for ultrasound scanning at 20 weeks gestation. After complete 167 
description of the study to the women, written informed consent was obtained by the study 168 
midwives, who then administered questionnaires and an interview in the clinic. 169 
Participants 170 
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Of those approached by study midwives, 68.4% gave consent and completed the measures, 171 
yielding an extensive sample of 1233 mothers with surviving singleton babies. The sampling 172 
flow chart has been published previously [35]. The mean age at recruitment of extensive sample 173 
participants was 26.8 years (s.d.5.8, range 18-51). Using the UK Index of Multiple Deprivation 174 
(IMD) [37] based on data collected from the UK Census in 2001, 36.6 % of the extensive 175 
sample reported socioeconomic profiles found in the most deprived UK quintile, consistent 176 
with the high levels of deprivation in some parts of the Wirral. Forty-eight women (3.9%) 177 
described themselves as other than White British.   178 
 In addition to assessments of the mothers at 20 weeks gestation, mothers and infants 179 
provided data at birth and postnatally at 5, 9, and 29 weeks, and at 14.19, s.d. 1.71 months (‘14 180 
months’), 30.86, s.d. 2.31 months (‘2.5 years’), 41.90 s.d. 2.48 months (‘3.5 years’) and 58.64 181 
s.d. 3.74 months (‘5 years’). Two hundred and sixty-eight mothers and infants came into the 182 
lab at 14 months for detailed observational, interview and physiological measures. This was 183 
the first occasion at which saliva for DNA was collected. Seven parents declined consent for 184 
DNA collection, 3 samples were spoilt, and 25 assessments were curtailed before saliva 185 
collection because of time constraints. Sufficient DNA for methylation analyses was obtained 186 
from 181 infants. Maternal reports of child anxious-depressed symptoms were available on 253 187 
of the intensive sub-cohort at 2.5 years, on 825 of the whole cohort at 3.5 years and on 768 of 188 
the whole cohort at 4.5 years. 189 
Measures 190 
Maternal depression. Maternal symptoms of depression were assessed at 20 weeks gestation 191 
and at every follow up point using the Edinburgh Postnatal Depression Scale (EPDS), which 192 
has been used extensively to assess prenatal and postnatal depression [38].  193 
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DNA methylation. Methylation status in the NR3C1 1-F promoter was examined at the same 194 
CpGs (CpG unit 22 and 23, shown in Figure 1) identified in previous studies (25). DNA 195 
collected from Oragene® saliva samples, was extracted, bisulphite treated, amplified (Forward, 196 
GACCTGGTCTCTCTGGGG; Reverse, TGCAACCCCGTAGCCCCTTTC) and run on a 197 
Sequenom EpiTYPER system (Sequenom Inc., San Diego, US), providing an average for 198 
methylation across the two CpG units. Data was transformed to percentage of methylation at 199 
CpG unit 22 and 23 to allow for comparison with previous analysis of differential methylation 200 
at this locus.  201 
 202 
 203 
Child anxious-depressed symptoms. Child symptoms were assessed by maternal report at 2.5, 204 
3.5 and 5.0 years using the preschool Child Behavior Checklist (CBCL) [38]. It has 99 items 205 
each scored 0 (not true), 1 (somewhat or sometimes true), and 2 (very true or often true), which 206 
are summed to create seven syndrome scales.  Only the anxious/depressed scale was analysed 207 
for this report, and as recommended in the CBCL manual, raw scores were used [40].   208 
Stratification variable and confounders . Partner psychological abuse was assessed using a 20 209 
item questionnaire covering humiliating, demeaning or threatening utterances in the partner 210 
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relationship during pregnancy over the previous year [41]. Maternal age (at this first 211 
pregnancy), marital status at 20 weeks gestation, and socioeconomic status were included as 212 
covariates because of their established associations with adult depression. Socioeconomic 213 
status was determined using the revised English Index of Multiple Deprivation (IMD) [37] 214 
based on neighborhood deprivation. All mothers were given IMD ranks according to the 215 
postcode of the area where they lived and assigned to a quintile, based on the UK distribution 216 
of deprivation. Mother’s years of education at enrolment in the study was recorded. Information 217 
about smoking was obtained at 20 and 32 weeks gestation and was included because of 218 
published associations with altered DNA methylation [42]. Birth records provided sex of 219 
infant, one-minute Apgar score, and birth weight and gestational age, from which a measure of 220 
fetal growth was obtained. Low fetal growth is associated with elevated fetal glucocorticoid 221 
exposure and so might be associated with elevated NR3C1 gene methylation. Obstetric risk 222 
was rated using a weighted severity scale developed by a collaboration of American and Danish 223 
obstetricians and paediatric neurologists [43]. 224 
Statistical Analysis 225 
 All analyses were undertaken in Stata 14 (StataCorp, 2015). Generalised structural 226 
equation models (SEM) were fitted using the sem procedure and estimated by maximum 227 
likelihood to allow inclusion of participants from both intensive and extensive strata. The 228 
anxiety-depression scores at 2.5, 3.5 and 5.0 years and NR3C1 percent methylation at 14 229 
months were highly skewed so scores were log-transformed and Winsorized at 2.5 standard 230 
deviations to reduce their skew. For further robustness, we report standard errors and p-values 231 
based on the heteroscedastic consistent estimator of the parameter covariance matrix.   The 232 
main analyses included the stratification variable and confounds except for perinatal confounds 233 
as they may lie on a mediational pathway from prenatal depression, however the effect of 234 
adding those variables was examined. Model estimates and tests allowed for differential 235 
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missingness associated with any of the covariates and observed responses included in the 236 
model, accounting for the stratified study design.  237 
The pre-post environment mismatch predictions on both methylation and child symptoms 238 
were examined first by testing for two-way interactions between prenatal and postnatal 239 
depression in models estimated separately in females and males. We then tested for the sex 240 
difference by examining the three-way, sex by prenatal depression by postnatal depression 241 
interactions in a model that included both genders. The effects of combinations of prenatal and 242 
postnatal depression giving rise to these interaction effects are shown in the figures. The 243 
prediction of additive effects of prenatal and postnatal depression in boys was examined in 244 
models without interaction terms. 245 
In the fitted models methylation was specified as a factor, measured without error by the 246 
observed methylation, a device that implicitly imputes rates of methylation where these have 247 
not been observed, but doing so in a manner which recognises our uncertainty in these 248 
unobserved values. This enables participants with partial data that would be informative for 249 
some parts of the model to be included.  250 
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Results 251 
Table 1 gives summary statistics for males and females separately for the measures 252 
included in the analysis and shows the sample size at each data collection point. As described 253 
in the statistical analysis section, differences in the available sample for different measures 254 
were accounted for by use of weighted, maximum likelihood or covariate adjusted estimators.  255 
Figure 2 shows the structure of the SEM model in which maternal history of depression predicts 256 
NR3C1 methylation (solid red arrows) and maternal report of child anxious-depressed 257 
symptoms (solid black arrows).  These analyses included the 412 girls and 382 boys on whom 258 
there were measures of maternal depression and maternal report of child anxious-depressed 259 
symptoms at a minimum of one follow up point as well as all confounders.  260 
 261 
  262 
Figure 2 Structural equation model fitted to NR3C1 1-F promoter methylation at 14 months and 263 
CBCL anxious-depressed scores at ages 2.5, 3.5, and 5 years   264 
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Table 1 Summary statistics for outcomes, predictors and variables included as potential 265 
confounders for the modelled sample (I = measure based on intensively assessed sub-sample 266 
only) 267 
 Girls Boys 
 N Mean 
 
SD N Mean 
 
SD 
Child anxious-depressed 
symptoms 2.5 years(I) 
125 1.54 1.77 120 1.27 1.61 
Child anxious-depressed 
symptoms 3.5 years 
387 1.60 1.64 366 1.59 1.70 
Child anxious-depressed 
symptoms 5 years 
372 1.76 1.96 347 1.78 2.01 
Child NR3C1 methylation(I) 89 3.42 1.85 87 3.55 1.96 
Prenatal EPDS maternal 
depression scores  
412 6.94 4.74 382 7.42 4.54 
Mean postnatal EPDS 
maternal depression scores 
412 5.24 3.92 382 5.79 4.35 
Stratum low 
412 
77%  
382 
75%  
Stratum mid 8%  7%  
Stratum high 16%  18%  
Maternal age <21 years  
412 
10%  
382 
12%  
Maternal age 21-30 years 56%  56%  
Maternal age >30 years 34%  32%  
No maternal education  
beyond age 18 
412 62%  382 67%  
Smoking – none 
412 
62%  
382 
64%  
Smoking before pregnancy 21%  19%  
Smoking during pregnancy 17%  18%  
No partner 412 17%  382 19%  
Most Deprived Quintile 412 37%  382 36%  
Obstetric risk index 412 2.20 1.18 382 2.20 1.19 
Birthweight/gestation 
(gm/wk) 
412 83.6 11.9 382 86.5 11.4 
1 Minute Apgar score 412 8.95 1.60 382 8.86 1.76 
 268 
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Table 2 shows for girls and boys separately the estimated path coefficients from the 269 
standardised prenatal depression, postnatal depression and their interaction (product) of 270 
primary interest accounting for the stratification, attrition and confounders. We first tested the 271 
prediction that there would be an interaction between prenatal and postnatal depression in girls 272 
but not in boys. In girls there was a significant effect of the interaction between prenatal and 273 
postnatal depression on both child anxiety-depression (p=.011) and NR3C1 1-F promoter 274 
methylation (p<.001). For boys, by contrast, anxious-depressed symptoms were not predicted 275 
by the prenatal and postnatal depression interaction term (p=.920), and the effect on NR3C1 276 
methylation was smaller than for girls, though still significant (p=.003). Adding the three 277 
additional potential confounders that were assessed after the prenatal exposure (obstetric risk 278 
index, 1-minute Apgar score and birthweight/gestational age) made no material difference to 279 
these associations. Fitting this model to boys and girls together,  but allowing the effects of 280 
prenatal and postnatal depression exposure on the two correlated outcomes to differ by sex (in 281 
addition to a gender main effect), a Wald test of the sex differences in the effect of the prenatal-282 
postnatal depression interaction on both outcomes (a difference of 0.20 for anxiety-depression 283 
and 0.18 for methylation)  gave 2(2) of 5.95 (p=.051), with the two individual interactions 284 
contributing equally (anxiety-depression p=.088, methylation p=.069).  285 
  286 
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Table 2 Summary of SEM analyses predicting NR3C1 1-F promoter methylation and child 287 
anxious depressed symptoms 288 
 289 
| Female (n=412) 
Std Coeff            95% C.I            
[p-value] 
Male (n=382) 
Std Coeff            95% C.I            
[p-value] 
Effects on child anxious-depressed symptoms 
  Prenatal maternal depression -0.06 -0.23, 0.11 0.16 -0.00, 0.33 
  Postnatal maternal depression 0.21 0.05, 0.38 0.17 0.03, 0.31 
  Prenatal-postnatal interaction -0.19 
[p=.011] 
-0.34,-0.05 0.01 
[p=.920] 
-0.11, 0.12 
Effects on child NR3C1 1-F promoter methylation 
  Prenatal maternal depression -.02 -0.28, 0.24 -0.11 -0.34, 0.12 
  Postnatal maternal depression 0.45 0.16, 0.75 0.38 0.11, 0.65 
  Prenatal-postnatal interaction -0.39 
[p=.00001] 
-0.56, -0.21 -0.21 
[p=.003] 
-0.32. -0.08 
Child anxious-depressed symptoms factor loadings 
2.5 years 0.81  0.72  
3.5 years 0.80  0.67  
5 years 0.57  0.81  
Model fit 
 RMSEA = .05 (95% 
C.I. .03-.07) CFI = .90 
RMSEA = .01 (95% 
C.I. .01-.04). CFI = 1.00  
 290 
Legend. The table shows standardized factor loadings of child CBCL anxious-depressed 291 
symptoms at ages 2.5, 3.5 and 5 years, and main effects and effects of interaction of prenatal 292 
and postnatal depression in the prediction of the anxious-depressed factor and the NR3C1 1-F 293 
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promoter methylation (effects of stratification factors and confounders not shown). Anxious-294 
depressed symptoms and methylation are analysed together as correlated outcomes in an 295 
SEM. Coefficients for the effects of confounders and stratification factors are not shown 296 
(stratum, maternal age, maternal smoking, maternal education, no partner, neighbourhood 297 
deprivation). The models reported used robust standard errors to guard against inferential 298 
errors due to non-normality. In order to provide conventional model fit statistics the models 299 
were run without robust standard errors and the statistics from this reported in the final row of 300 
the table. 301 
 302 
  303 
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We then tested the prediction that in boys there would be independent and additive effects 304 
of prenatal and postnatal depression, by estimating the model (not shown in the Table) for boys 305 
without the interaction term. This showed a significant effect on child anxiety-depression of 306 
postnatal depression (standardised coefficient 0.17, CI 0.04 to 0.30, p = .011) and an effect of 307 
similar magnitude, that was non-significant, of prenatal depression (0.15, CI -0.02 to 0.33, 308 
p=.080). Independent effects on methylation were not seen (prenatal 0.05, CI -0.17 to 0.27, 309 
p=.640; postnatal 0.13, CI -.09 to 0.36, p=.241).   310 
Figure 3 displays how the interactions between prenatal and postnatal depression in the 311 
prediction of anxious-depressed symptoms differed between girls and boys. It can be seen that 312 
in girls, at a low level of prenatal depression (1 standard deviation below the mean), increasing 313 
postnatal depression was strongly associated with increasing child anxious-depressed 314 
symptoms, while at a high level there was no association. With prenatal depression at the mean, 315 
the association was intermediate between the low and high prenatal levels. In boys, by contrast, 316 
as evidenced in parallel regression lines, there was no interplay between prenatal and postnatal 317 
maternal depression.  318 
  319 
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As shown in Figure 4, the effects of prenatal-postnatal mismatch on methylation were 320 
again strongly evident in girls, with the greatest association between postnatal depression and 321 
methylation in the presence of low prenatal depression, and progressively weaker associations 322 
at higher levels of prenatal depression. The progressive effect of prenatal depression was also 323 
evident in boys but was less strong.  324 
 325 
 326 
In girls, replacing the correlation between the methylation and anxiety-depression factors 327 
by a causal effect, higher NR3C1 methylation at 14 months was associated with higher anxiety-328 
depressed symptoms (standardised coefficient 0.36 CI  0.05 to 0.67, p=.025), illustrated in the 329 
left hand panel of Figure 5. The residual direct effect of the prenatal-postnatal interaction on 330 
child anxiety-depression symptoms was substantially reduced, from -0.19 (shown in Table 2) 331 
to -0.06 (CI -0.26 to 0.15), becoming wholly nonsignificant (p=.600).  For boys there was no 332 
evidence of an effect of methylation on symptoms (standardised coefficient -0.03, CI -0.31 to 333 
0.24, p=.820). 334 
 335 
  20
   
 
  336 
  21
   
 
Discussion 337 
Many, although not all, of our predictions based on the evolutionary T-W and PAR hypotheses 338 
for sex-biased parental investment and fetal programming were supported in this longitudinal 339 
study, from 20 weeks of pregnancy and over the first 5 years of children’s lives. Mismatching 340 
between prenatal and postnatal maternal depression was associated with greater anxious-341 
depressed symptoms and NR3C1 methylation in girls. Both effects were most evident in girls 342 
exposed to high levels of postnatal depression. Their symptoms and NR3C1 methylation were 343 
higher where their mothers had reported low levels of depression during pregnancy, in line 344 
with the idea that they had not been prepared by the fetal environment for postnatal exposure 345 
to maternal depression. In girls only, elevated NR3C1 was associated with higher anxious-346 
depressed symptoms and mediated the association between maternal depression and child 347 
symptoms. In boys, there was no evidence of effects of prenatal – postnatal depression 348 
mismatch on anxious-depressed symptoms. However, and contrary to our prediction, the 349 
prenatal-postnatal mismatch effect on NR3C1 methylation was seen in boys as well as in girls, 350 
although the size of the effect was smaller.  351 
The strengths of the investigation include a prospective study with a general population 352 
sample, accounting for a number of plausible confounds and factors associated with attrition. 353 
Also, by using SEM to create a latent variable from measurement at 3 time points over 2.5 354 
years, we reduced the risks arising from multiple testing for each time point, and we were able 355 
to examine the predictions in relation to persistently elevated symptoms likely to confer risk 356 
for an elevated trajectory for anxious-depressed symptoms over childhood [44]. The method 357 
adopted for missing methylation data exploited the properties of maximum likelihood for 358 
accounting for data assumed missing at random. Most missingness was by design because of 359 
the systematic stratification of the intensive sample, thus meeting this assumption, and 360 
inclusion of multiple covariates allowed us account for unplanned attrition. It is nevertheless 361 
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possible that not all the necessary confounds to deal with non-random missingness were 362 
identified.  363 
There were four principal limitations in relation to the measurement of NR3C1 364 
methylation. First, peripheral cell samples, both from blood and saliva, are heterogeneous, 365 
which may account for some of the variability in methylation. This can introduce a confound 366 
where other variables are associated with cellular heterogeneity [45]. Second, while studies 367 
combining peripheral cell and CNS post mortem estimations suggest that they are often 368 
substantially correlated [45], it cannot be assumed that DNA methylation in peripheral tissues 369 
reflects methylation in relevant CNS regions. This is particularly a concern because of 370 
substantial variations in epigenetic effects across brain regions and cell types. Specifically, it 371 
cannot be assumed that variations in the NR3C1 1-F promoter in saliva reflect variations in 372 
glucocorticoid receptor synthesis in the hippocampal regions involved in HPA axis regulation.  373 
Third DNA methylation is one of a number of an epigenetic processes that regulate gene 374 
expression, and so does not provide a direct measure of that expression. ‘Mediation’ in this 375 
report, as in the field more widely [47], refers to statistical findings consistent with, but not 376 
direct evidence of, epigenetic mediation. Fourth, there are many combinations of CpG sites, 377 
even on a relatively circumscribed region such as the NR3C1 1-F promoter that could be 378 
examined, leading to the risk of multiple analyses and ‘significant’ findings occurring by 379 
chance. Fifth, although we accounted for several plausible confounds, environmental variables 380 
other than those included in analyses may better account for the findings.  381 
No one study can establish the validity of estimates of peripheral cell methylation as 382 
indices of CNS methylation, however a finding of the same pattern of associations for 383 
peripheral cell methylation and for behaviours that undoubtedly reflect CNS function, and for 384 
mediation of the association between maternal depression and symptoms by NR3C1 385 
methylation is relevant to the issue. As is evident from the SEM models, and as seen in Figures 386 
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3 and 4, there were striking similarities between the patterns of associations involving 387 
interactions between prenatal and postnatal depression and sex differences, not only for child 388 
anxious-depressed symptom but also for NR3C1 methylation.  Furthermore, in this study we 389 
reduced risks arising from multiple analyses of many potential methylation sites by examining 390 
only one site that had been identified from a meta-analysis of previous studies [25].   391 
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Conclusions 392 
Our findings are important in five major ways. First, they provide pointers to study 393 
designs that could be introduced into animal models where mechanisms can be examined using 394 
experimentally controlled risks. These would, for example, examine the interplay between 395 
prenatal and postnatal risks in relation to the role of the placenta in regulating passage of 396 
maternal glucocorticoids to the foetus, which in turn can be controlled by further epigenetic 397 
modifications of specific placental genes [47]. Second, they illustrate how evolutionary 398 
hypotheses regarding parental investment in offspring can be used to generate novel, and in 399 
some ways surprising, predictions regarding parenting and early development in humans 400 
[10,48].  Third, testing in this way can generate further productive questions. In this study, 401 
while there was good evidence for mismatch effects in females on NR3C1 methylation and 402 
child symptoms, and for a sex difference in relation to child symptoms, the prenatal-postnatal 403 
depression mismatch was also associated with NR3C1 methylation in males, which was 404 
contrary to the predictions. Further study is needed into the conditions under which fetal 405 
programming effects are seen in males as well as females, and under what conditions there are 406 
sex differences in the behavioural implications of NR3C1 methylation. Fourth they show that, 407 
even though human development is subject to many complex social and psychological 408 
influences, biological mechanisms conserved across many non-human species, can be highly 409 
influential. Fifth they suggest that some prenatal effects on epigenetic and behavioural 410 
outcomes in early childhood, differ radically in males and females, and so further study of sex 411 
specific mechanisms is needed. This will have implications for our understanding of the 412 
biology of psychiatric disorders arising in childhood.   413 
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